Skip to main content

Table 3 Immunoassays of blood Insulin, HOMA-IR, Cortisol and Testosterone (in men) in people with treated T2D before (baseline) and after treatment (24-week) within Main (Experimental) and Control (Conventional) groups (M ± SEM)

From: Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial

Variables Main group, n = 208 Control group, n = 64
Baseline 24-week Baseline 24-week
Immunoassay insulin (nU/L) 23.2 ± 1.0 6.5 ± 0.3* 20.9 ± 1.2 15.0 ± 1.2*
Immunoassay cortisol (nmol/L) 751.2 ± 6.7 445.7 ± 5.3* 747.2 ± 8.9 739.5 ± 9.1
HOMA-IR index 8.9 ± 0.44 1.30 ± 0.29* 7.97 ± 0.53 4.03 ± 0.55*
Variable in men
  Main group, n = 99 Control group, n = 30
Blood testosterone (ng/dL) 365.9 ± 13.8 885.2 ± 21.2* 379.2 ± 19.6 395.2 ± 24.5
  1. Abbreviations: ANADET analimentary detoxication, HOMA-IR Homeostasis Model Assessment insulin resistance index, IR insulin resistance, M mean, SEM standard error of the mean, T2D type 2 diabetes
  2. *P < 0.0001 were set as significant between baseline and 24-week treatment within group comparison